These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 36654790)
1. A comparative study on the production of extracellular hydrolytic enzymes of Fathi F; Zarei Mahmoudabadi A; Fatahinia M Curr Med Mycol; 2022 Jun; 8(2):32-39. PubMed ID: 36654790 [TBL] [Abstract][Full Text] [Related]
2. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species. Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443 [TBL] [Abstract][Full Text] [Related]
3. Potential Pathogenicity of Nouraei H; Jahromi MG; Jahromi LR; Zomorodian K; Pakshir K Biomed Res Int; 2021; 2021():9982744. PubMed ID: 34136578 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of Candida species in AIDS patients and HIV-free subjects in Thailand. Teanpaisan R; Nittayananta W J Oral Pathol Med; 1998 Jan; 27(1):4-7. PubMed ID: 9466727 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of virulence attributes in oral Candida albicans isolates from human immunodeficiency virus-positive individuals. Mane A; Gaikwad S; Bembalkar S; Risbud A J Med Microbiol; 2012 Feb; 61(Pt 2):285-290. PubMed ID: 21959206 [TBL] [Abstract][Full Text] [Related]
6. Comparison of enzymatic activities in different Candida species isolated from women with vulvovaginitis. Fatahinia M; Halvaeezadeh M; Rezaei-Matehkolaei A J Mycol Med; 2017 Jun; 27(2):188-194. PubMed ID: 28236530 [TBL] [Abstract][Full Text] [Related]
7. Oropharyngeal candidiasis in HIV/AIDS patients and non-HIV subjects in the Southeast of Iran. Hosain Pour A; Salari S; Ghasemi Nejad Almani P Curr Med Mycol; 2018 Dec; 4(4):1-6. PubMed ID: 30815610 [TBL] [Abstract][Full Text] [Related]
8. High detection of virulence factors by Candida species isolated from bloodstream of patients with candidemia. Nouraei H; Pakshir K; ZareShahrabadi Z; Zomorodian K Microb Pathog; 2020 Dec; 149():104574. PubMed ID: 33075515 [TBL] [Abstract][Full Text] [Related]
10. Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals. Anil S; Hashem M; Vellappally S; Patil S; Bandara HM; Samaranayake LP Mycopathologia; 2014 Oct; 178(3-4):207-15. PubMed ID: 25142726 [TBL] [Abstract][Full Text] [Related]
11. [Proteinase activity in Candida albicans strains isolated from the oral cavity of immunocompromised patients, with oral candidiasis and in healthy subjects]. Hernández-Solís SE; Rueda-Gordillo F; Rojas-Herrera RA Rev Iberoam Micol; 2014; 31(2):137-40. PubMed ID: 24071641 [TBL] [Abstract][Full Text] [Related]
12. Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria. Enwuru CA; Ogunledun A; Idika N; Enwuru NV; Ogbonna F; Aniedobe M; Adeiga A Afr Health Sci; 2008 Sep; 8(3):142-8. PubMed ID: 19357740 [TBL] [Abstract][Full Text] [Related]
13. Virulence of Candida albicans isolated from HIV infected and non infected individuals. Wibawa T; Praseno ; Aman AT Springerplus; 2015; 4():408. PubMed ID: 26266079 [TBL] [Abstract][Full Text] [Related]
14. Are Candida albicans isolates from the oral cavity of HIV-infected patients more virulent than from non-HIV-infected patients? Systematic review and meta-analysis. Orlandini RK; Bepu DAN; Saraiva MDCP; Bollela VR; Motta ACF; Lourenço AG Microb Pathog; 2020 Dec; 149():104477. PubMed ID: 32920148 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of Oropharyngeal Candidiasis and distribution of Musinguzi B; Obuku EA; Kinengyere AA; Ndagire R; Baguma A; Mwesigwa A; Itabangi H; Mboowa G; Sande OJ; Achan B Res Sq; 2024 Jun; ():. PubMed ID: 38883750 [TBL] [Abstract][Full Text] [Related]
16. Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates. Junqueira JC; Fuchs BB; Muhammed M; Coleman JJ; Suleiman JM; Vilela SF; Costa AC; Rasteiro VM; Jorge AO; Mylonakis E BMC Microbiol; 2011 Nov; 11():247. PubMed ID: 22053894 [TBL] [Abstract][Full Text] [Related]
17. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of exoenzyme profiles of Nouraei H; Razeghian Jahromi L; Ghaderian Jahromi M; Zomorodian K; Pakshir K Curr Med Mycol; 2023 Dec; 9(4):51-54. PubMed ID: 38983612 [TBL] [Abstract][Full Text] [Related]
19. Exoenzyme activity and possibility identification of Candida dubliniensis among Candida albicans species isolated from vaginal candidiasis. Jafari M; Salari S; Pakshir K; Zomorodian K Microb Pathog; 2017 Sep; 110():73-77. PubMed ID: 28642006 [TBL] [Abstract][Full Text] [Related]
20. The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects. De Bernardis F; Boccanera M; Rainaldi L; Guerra CE; Quinti I; Cassone A Eur J Epidemiol; 1992 May; 8(3):362-7. PubMed ID: 1356827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]